| Literature DB >> 30100076 |
Deepa Narayanan1, Wendie A Berg2.
Abstract
Recent advances in nuclear medicine instrumentation have led to the emergence of improved molecular imaging techniques to image breast cancer: dedicated gamma cameras using γ-emitting 99mTc-sestamibi and breast-specific PET cameras using 18F-fluorodeoxyglucose. This article focuses on the current role of such approaches in the clinical setting including diagnosis, assessing local extent of disease, monitoring response to therapy, and, for gamma camera imaging, possible supplemental screening in women with dense breasts. Barriers to clinical adoption and technologies and radiotracers under development are also discussed. Published by Elsevier Inc.Entities:
Keywords: Breast PET; Breast PET tracers; Breast cancer; Molecular breast imaging; Positron emission mammography
Mesh:
Year: 2018 PMID: 30100076 PMCID: PMC6116731 DOI: 10.1016/j.cpet.2018.02.008
Source DB: PubMed Journal: PET Clin ISSN: 1556-8598